Biologics Flashcards

1
Q

What is the PBS criteria for dupilumab?

A

12 years of age or older
Disease duration >6 months
EASI score of 20 or more
PGA score of 4
Sole PBS subsidised biologic for this indication
Not previously failed this biologic for this indication
Use of medium-high potency topical corticosteroid for last (at least) 4 weeks
Patient treated by dermatologist or clinical immunologist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the contraindications to dupilumab?

A

Hypersensitivity
Pregnancy/lactation
Helminth infestation
HsV keratitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the adverse effects of dupilumab?

A

Common: injection site reaction, conjunctivitis, URTI, HSV

Serious: hypersensitivity reaction, serum sickness like reaction, eosinophilic pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What baseline and ongoing monitoring is needed for dupilumab?

A

Baseline: immunosuppression screen + strongyloides

Ongoing: nil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the PBS criteria for omalizumab?

A

Severe CSU of at least 6 weeks duration despite use of H1 antihistamines
Failed at least 2 weeks of standard therapy (H1, H2, montelukast, doxepin)
UAS7 score of at least 28
Itch score of at least 8
Exclusion of physical triggers
Treated by dermatologist, allergist, clinical immunologist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is omalizumab dosed and initiated?

A

300mg every 4 weeks subcutaneously

First 3 doses need to be supervised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the contraindications to omalizumab?

A

Hypersensitivity
Previous anaphylaxis
Pregnancy/lactation
Latex allergy
Helminth infestation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the adverse effects of omalizumab?

A

Common: LISR, URTI sx, GI effects, arthralgias

Rare: anaphylaxis, serum sickness-like reactions, helminth infestation

MI, CVA, VTE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the contraindications to the IL-17 blockers?

A

Hypersensitivity
Pregnancy/lactation
IBD
Candidal infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the adverse effects of the IL-17 blockers?

A

Common: LISR, URTI sx, oral candidiasis, headache, diarrhoea

Rare/serious: hypersensitivity reactions, IBD, neutropenia, NMSC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the two IL-17 blockers used in Australia and what are their dosing regimes?

A

Ixekizumab
- 160mg loading
- 80mg every 2 weeks for 3 months
- 80mg monthly

Secukinumab
- 300mg loading
- 300mg weekly for 1 month
- 300mg monthly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the contraindications to the IL-12/23 blockers?

A

Hypersensitivity
Pregnancy/lactation
Active/recently-treated infection
Active/recently-treated malignancy
High risk of ACS/CVA (ustekinumab)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the adverse effects of the IL-12/23 blockers?

A

Common: local injection site reaction, URTI sx, GI effects, UTI

Serious: hypersensitivity, reactivation of infection or malignancy

Ustekinumab specific
- posterior reversible encephalopathy syndrome
- major cardiovascular events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the IL-12/23 blockers used in Australia and how are they dosed?

A

Ustekinumab
<100kg 45mg
>100kg 90mg
Given at weeks 0, 4 and then 3 monthly

Guselkumab
100mg, week 0, 4 and then every 2 months

Tildrakizumab
100mg, week 0, 4 and then every 3 months

Rizankizumab
150mg, week 0, 4 and then every 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What baseline and ongoing monitoring is required for IL-12/23 blockers?

A

Baseline
Full examination inc. skin and LNs
FBC, UEC, LFT, BhCG, BSL, lipids
Immunosuppression screen

Ongoing
FBC, UEC, LFT every 6 months
BSL, lipids, immunosuppression screen every 12/12 or as risk changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the non psoriasis indications for TNF inhibitors?

A

Hidradenitis suppurativa
Granulomatous disease
Neutrophilic dermatosis
Pityriasis rubra pilaris
SJS/TEN

17
Q

What are the contraindications to TNF inhibitors?

A

Hypersensitivity
Pregnancy/lactation
Heart failure
Multiple sclerosis
Active/recently treated infection/malignancy

18
Q

What are the adverse effects of TNF inhibitors?

A

Common: LISR, URTI, headache

Serious:
Hypersensitivity reactions
Infection & malignancy
Exacerbation of CCF or MS
Cytopaenias
Hepatotoxicity
SJS/TEN

Skin
vasculitis
Subacute lupus
Lichenoid drug eruption
Pityriasiform eruption
Sweet syndrome
Granulomatous: EN, Sarcoidosis, granuloma annulare

19
Q

What are the TNF inhibitors used in Australia and what are their dosing regimes?

A

Infliximab 5mg/kg
Weeks 0, 2 & 6 and then every 2 months

Etanercept 50mg Weekly

Adalimumab
80mg loading dose
40mg every 2 weeks

Certolizumab 200-400mg every 2 weeks

20
Q

What are the contraindications to rituximab?

A

Hypersensitivity, Hx of angiooedema, bronchospasm, hypotension
Pregnancy
Active/recent treated infection/cancer
Immunodeficiency
Progressive multifocal leukoencephalopathy
Severe cardiac failure

21
Q

What drugs interact with rituximab?

A

Live vaccines
Other monoclonal antibodies
Other immunosuppressants
Cytotoxic agents

22
Q

What are the side effects of rituximab?

A

Infusion reactions, anaphylaxis
URTI sx
GI: nausea, bowel obstruction/perforation
CNS: headache, dizziness, tremor
Cytopaenias
Infections eg. JC virus, HBV
Malignancy, tumour lysis syndrome

23
Q

How do you administer rituximab for pemphigus?

A

30 mins before
- cetirizine 10mg PO
- paracetamol 1g PO
- hydrocortisone 100mg IV

1g rituximab STAT, repeat 2 weeks later, repeat at 6-12 months
Monitor for 2 hours post infusion
Consider PCP prophylaxis

24
Q

What monitoring is required for rituximab?

A

FBC after each dose, then 1-3 monthly
B cell subsets, Ig every 3-6 months

25
What baseline screening is required for rituximab?
Hx and exam (infection, malignancy, skin check) Vaccinations up to date Contraception 12 months after last dose FBC, UEC, LFT, BHcG, age appropriate malignancy screen Immunosuppression screen, B cell subsets